...
机译:SKLB-23BB,AHDAC6选择性抑制剂,通过另外靶向微管呈现优异的和广谱抗肿瘤活性
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
Sichuan Univ West China Hosp Collaborat Innovat Ctr Biotherapy State Key Lab Biotherapy Chengdu;
机译:SKLB-23BB,AHDAC6选择性抑制剂,通过另外靶向微管呈现优异的和广谱抗肿瘤活性
机译:BF12是一种新型苯并呋喃,通过抑制人类宫颈癌细胞中的微管和PI3K / AKT / MTOR信号传导途径来表现出抗肿瘤活性
机译:基于秋水仙碱的新型微管抑制剂通过诱导线粒体介导的MIA PaCa-2胰腺癌细胞凋亡显示出强大的抗肿瘤活性。
机译:抗凋亡Bcl-2家族蛋白的广谱小分子抑制剂的设计,合成和活性评估:广谱蛋白结合的特征及其对抗肿瘤活性的影响
机译:PD-L1特异性辅助性T细胞表现出有效的抗肿瘤反应:针对头颈部鳞状细胞癌中PD-L1的癌症免疫疗法的新策略。
机译:克服多药耐药性的新型硝基苯甲酸酯微管抑制剂表现出抗肿瘤活性。
机译:SKLB-23BB,HDAC6选择性抑制剂,通过另外靶向微管呈现优异的和广谱抗肿瘤活性